141 related articles for article (PubMed ID: 10320045)
21. Synthesis of double-headed 2-5A-antisense chimeras and their ability to activate human RNase L.
Ueno Y; Okatani S; Yamada Y; Kitade Y
Bioorg Med Chem Lett; 2003 Nov; 13(22):3959-61. PubMed ID: 14592484
[TBL] [Abstract][Full Text] [Related]
22. Selective RNA cleavage by isolated RNase L activated with 2-5A antisense chimeric oligonucleotides.
Silverman RH; Dong B; Maitra RK; Player MR; Torrence PF
Methods Enzymol; 2000; 313():522-33. PubMed ID: 10595377
[No Abstract] [Full Text] [Related]
23. 2',5'-Oligoadenylate:antisense chimeras--synthesis and properties.
Lesiak K; Khamnei S; Torrence PF
Bioconjug Chem; 1993; 4(6):467-72. PubMed ID: 8305516
[TBL] [Abstract][Full Text] [Related]
24. Targeting RNA for degradation with a (2'-5')oligoadenylate-antisense chimera.
Torrence PF; Maitra RK; Lesiak K; Khamnei S; Zhou A; Silverman RH
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1300-4. PubMed ID: 7679499
[TBL] [Abstract][Full Text] [Related]
25. The quest for an efficacious antiviral for respiratory syncytial virus.
Torrence PF; Powell LD
Antivir Chem Chemother; 2002 Nov; 13(6):325-44. PubMed ID: 12718405
[TBL] [Abstract][Full Text] [Related]
26. Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase.
Liuzzi M; Mason SW; Cartier M; Lawetz C; McCollum RS; Dansereau N; Bolger G; Lapeyre N; Gaudette Y; Lagacé L; Massariol MJ; Dô F; Whitehead P; Lamarre L; Scouten E; Bordeleau J; Landry S; Rancourt J; Fazal G; Simoneau B
J Virol; 2005 Oct; 79(20):13105-15. PubMed ID: 16189012
[TBL] [Abstract][Full Text] [Related]
27. Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo.
Jin H; Zhou H; Cheng X; Tang R; Munoz M; Nguyen N
Virology; 2000 Jul; 273(1):210-8. PubMed ID: 10891423
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of respiratory syncytial virus in cultured cells by nucleocapsid gene targeted deoxyribozyme (DNAzyme).
Xie YY; Zhao XD; Jiang LP; Liu HL; Wang LJ; Fang P; Shen KL; Xie ZD; Wu YP; Yang XQ
Antiviral Res; 2006 Aug; 71(1):31-41. PubMed ID: 16687180
[TBL] [Abstract][Full Text] [Related]
29. Incorporation of a 4-hydroxy-N-acetylprolinol nucleotide analogue improves the 3'-exonuclease stability of 2'-5'-oligoadenylate-antisense conjugates.
Verheijen JC; van Roon AM; Meeuwenoord NJ; Stuivenberg HR; Bayly SF; Chen L; van der Marel GA; Torrence PF; van Boom JH
Bioorg Med Chem Lett; 2000 Apr; 10(8):801-4. PubMed ID: 10782690
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of growth of estrogen receptor positive and estrogen receptor negative breast cancer cells in culture by AA-etherA, a stable 2-5A derivative.
Latham KE; Cosenza S; Reichenbach NL; Mordechai E; Adelson ME; Kon N; Horvath SE; Charubala R; Mikhailov SN; Pfeiderer W; Suhadolnik RJ
Oncogene; 1996 Feb; 12(4):827-37. PubMed ID: 8632905
[TBL] [Abstract][Full Text] [Related]
31. Nuclease-resistant composite 2',5'-oligoadenylate-3', 5'-oligonucleotides for the targeted destruction of RNA: 2-5A-iso-antisense.
Xiao W; Li G; Player MR; Maitra RK; Waller CF; Silverman RH; Torrence PF
J Med Chem; 1998 Apr; 41(9):1531-9. PubMed ID: 9554886
[TBL] [Abstract][Full Text] [Related]
32. Methods for the characterization of phosphatase-stabilized 2-5A-antisense chimeras.
Player MR; Xiao W; Cramer H; Torrence PF
Bioconjug Chem; 1998; 9(1):137-42. PubMed ID: 9460557
[TBL] [Abstract][Full Text] [Related]
33. Using fluorescence resonance energy transfer (FRET) for measuring 2-5A analogues ability to activate RNase L.
Cramer H; Geselowitz DA; Torrence PF
Nucleosides Nucleotides; 1999; 18(6-7):1523-5. PubMed ID: 10474231
[TBL] [Abstract][Full Text] [Related]
34. RNase L and 2-5A to enhance antisense technology and target the destruction of mRNA.
Glaser V
Mol Med Today; 1996 May; 2(5):183. PubMed ID: 8796884
[No Abstract] [Full Text] [Related]
35. Catalytic cleavage of an RNA target by 2-5A antisense and RNase L.
Maitra RK; Li G; Xiao W; Dong B; Torrence PF; Silverman RH
J Biol Chem; 1995 Jun; 270(25):15071-5. PubMed ID: 7797490
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of double-headed 2-5A-antisense chimeras and their ability to activate human RNase L.
Ueno Y; Okatani S; Yamada Y; Kitade Y
Nucleic Acids Res Suppl; 2003; (3):63-4. PubMed ID: 14510381
[TBL] [Abstract][Full Text] [Related]
37. 2-5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells.
Kushner DM; Paranjape JM; Bandyopadhyay B; Cramer H; Leaman DW; Kennedy AW; Silverman RH; Cowell JK
Gynecol Oncol; 2000 Feb; 76(2):183-92. PubMed ID: 10637068
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of antisense oligonucleotides carrying modified 2-5A molecules at their 5'-termini and their properties.
Ueno Y; Kato Y; Okatani S; Ishida N; Nakanishi M; Kitade Y
Bioconjug Chem; 2003; 14(3):690-6. PubMed ID: 12757397
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and properties of second-generation 2-5A-antisense chimeras with enhanced resistance to exonucleases.
Li G; Xiao W; Torrence PF
J Med Chem; 1997 Aug; 40(18):2959-66. PubMed ID: 9288179
[TBL] [Abstract][Full Text] [Related]
40. Recombinant respiratory syncytial virus with the G and F genes shifted to the promoter-proximal positions.
Krempl C; Murphy BR; Collins PL
J Virol; 2002 Dec; 76(23):11931-42. PubMed ID: 12414935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
